EID1 suppresses lipid accumulation by inhibiting the expression of GPDH in 3T3-L1 preadipocytes
- PMID: 32056205
- DOI: 10.1002/jcp.29567
EID1 suppresses lipid accumulation by inhibiting the expression of GPDH in 3T3-L1 preadipocytes
Abstract
The imbalance between food intake and energy expenditure causes high accumulation of triglycerides in adipocytes. Obesity is related with the increased lipid accumulation in white adipose tissue, which is a major risk factor for the development of metabolic disorders, such as type 2 diabetes and cardiovascular disease. This study highlights the role of E1A-like inhibitor of differentiation 1 (EID1) in the modulation of adipogenesis through the downregulation of glycerol-3-phosphate dehydrogenase (GPDH), which is a key enzyme in the synthesis of triglycerides and is considered to be a marker of adipogenesis. By analyzing DNA microarray data, we found that when EID1 is overexpressed in preadipocytes (3T3-L1 cells) during adipocyte differentiation, EID1 inhibits lipid accumulation through the downregulation of GPDH. In contrast, EID1 is not involved in the regulation of intracellular glucose via the translocation of glucose transporter. A confocal image analysis showed that EID1 is located in the nucleus of preadipocytes in the form of speckles, which could be involved as a regulator of the transcriptional process. We further confirmed that EID1 is able to bind to the promoter sequence of GPDH in the nucleus. These findings provide a molecular explanation for the inhibitory effect of EID1 on lipid accumulation in adipocytes.
Keywords: DNA microarray; EID1; GPDH; adipogenesis; preadipocytes 3T3-L1.
© 2020 Wiley Periodicals, Inc.
References
REFERENCES
-
- Båvner, A., Johansson, L., Toresson, G., Gustafsson, J. A., & Treuter, E. (2002). A transcriptional inhibitor targeted by the atypical orphan nuclear receptor SHP. EMBO Reports, 3(5), 478-484. https://doi.org/10.1093/embo-reports/kvf087
-
- Festuccia, W. T., Blanchard, P. G., Turcotte, V., Laplante, M., Sariahmetoglu, M., Brindley, D. N., … Deshaies, Y. (2009). The PPARγ agonist rosiglitazone enhances rat brown adipose tissue lipogenesis from glucose without altering glucose uptake. American Journal of Physiology Regulatory Integrative Comparative Physiology, 296(5), R1327-R1335. https://doi.org/10.1152/ajpregu.91012.2008
-
- Gallagher, E. J., & LeRoith, D. (2015). Obesity and diabetes: The increased risk of cancer and cancer-related mortality. Physiological Reviews, 95(3), 727-748. https://doi.org/10.1152/physrev.00030.2014
-
- Ge, X., Yin, L., Ma, H., Li, T., Chiang, J. Y., & Zhang, Y. (2011). Aldo-keto reductase 1B7 is a target gene of FXR and regulates lipid and glucose homeostasis. Journal of Lipid Research, 52(8), 1561-1568. https://doi.org/10.1194/jlr.M015859
-
- Girnun, G. D., Domann, F. E., Moore, S. A., & Robbins, M. E. (2002). Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Molecular Endocrinology, 16(12), 2793-2801. https://doi.org/10.1210/me.2002-0020
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
